l-Glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes

Eur J Pharmacol. 1984 Apr 13;100(1):127-30. doi: 10.1016/0014-2999(84)90326-1.

Abstract

l-Glutamate but not methyl-D-aspartate (NMDA) or quisqualate ( Quis ) (10(-6 M) in vitro with or without preincubation increased significantly the KD value of the [3H]N-propylnorapomorphine ( [3H]NPA) binding sites by 21 and 36% respectively in striatal membranes of rat without influencing the striatal [3H]spiperone binding sites. The number of striatal [3H]NPA binding sites was not changed by l-glutamate (10(-6) and 10(-5) M) in vitro. There may thus exist interactions between striatal glutamate receptors -- not related to excitatory amino-acid receptors of the NMDA or the QUIS type -- and high affinity striatal DA receptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antiparkinson Agents / metabolism*
  • Apomorphine / analogs & derivatives*
  • Apomorphine / metabolism
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / pharmacology
  • Binding Sites / drug effects
  • Cell Membrane / metabolism
  • Corpus Striatum / metabolism*
  • Corpus Striatum / ultrastructure
  • Glutamates / pharmacology*
  • Glutamic Acid
  • Male
  • N-Methylaspartate
  • Neuromuscular Depolarizing Agents / pharmacology
  • Oxadiazoles / pharmacology
  • Quisqualic Acid
  • Rats
  • Rats, Inbred Strains
  • Spiperone / metabolism

Substances

  • Antiparkinson Agents
  • Glutamates
  • Neuromuscular Depolarizing Agents
  • Oxadiazoles
  • Aspartic Acid
  • Glutamic Acid
  • Spiperone
  • N-n-propylnorapomorphine
  • N-Methylaspartate
  • Quisqualic Acid
  • Apomorphine